Arbutus Biopharma (ABUS) Net Equity Issued and Repurchased (2013 - 2026)
Arbutus Biopharma's Net Equity Issued and Repurchased came in at $3.15 million for Q2 2026, up 594.9% from $453,000 a year earlier but down 72.7% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arbutus Biopharma reported Net Equity Issued and Repurchased of $17.11 million, up 179.7% year-over-year; for FY2025, it came in at $5.54 million, down 25.9% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -42.3% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $7.48 million in FY2024, $535,000 in FY2023 (+35.4%), $395,000 in FY2022 (-81.3%) and $2.11 million in FY2021 (-97.6%).
- The five-year range for quarterly Net Equity Issued and Repurchased is -$115,000 (Q4 2021) to $11.53 million (Q1 2026).
- Year-over-year, Net Equity Issued and Repurchased has increased for three consecutive quarters, with growth averaging 183.3% over the last seven quarters.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2024 (growth of 729.1%), and the weakest in Q3 2021 (a decline of 95.9%).
- Business Quant data shows ABUS's Net Equity Issued and Repurchased at $11.53 million (Q1 2026), $1.64 million (Q4 2025) and $794,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - | 3.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Mn |
| Mar 31, 2026 | 11.53 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 794,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 285,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | -115,000.00 |
| Sep 30, 2021 | 1.98 Mn |
| Mar 31, 2021 | 247,000.00 |
| Dec 31, 2020 | 20.18 Mn |
| Sep 30, 2020 | 48.76 Mn |
API Access
Arbutus Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();